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Interferon treatment for hepatitis C virus infection in patients on hemodialysis. Nephrol Dial Transplant 1997; 12: 1414 -1419 1994 7: 124-127 18. Lombardi M, Cerrai T, Dattolo P, Pizzarelli F, Michelassi S, 9. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Maggiore Q, Zignego AL. Is the dialysis membrane a safe Vinson S, Mousa M, Gitnick G. Introduction mortality in renal transplant recipients, particularly after the first year [3] . Since many of these individuals Advances in immunosuppressive therapy and in the die with functioning transplants, these deaths represent treatment of opportunistic infection have greatly an increasingly important cause of graft loss. In one improved outcomes following renal transplantation, study from Scandinavia, more grafts were lost from unmasking the clinical importance of co-morbid condipatient mortality than rejection during the 2-5 year tions associated with uraemia. It is now well established post-transplant period (49 vs 41%). Ischaemic heart that patients with chronic renal failure are at increased disease and other vascular events collectively accounted risk of cardiovascular disease [1] . Long-term followfor 63% of these deaths [4] . up studies suggest that this problem is attenuated, but Efforts to extend patient and graft survival will is not corrected, by successful renal transplantation therefore become increasingly dependent on approeven when biases resulting from patient selection are priate prevention and management of cardiovascular taken into account [2] . Cardiovascular disease has now disease, rather than on further advances in immunosuppressive or antimicrobial therapy. The following artery disease from transplant waiting lists and how Dopamine stress echocardiography looks the most promising with a reported sensitivity of 95% and the chances of developing disease might be minimized by appropriate risk factor modification. These specificity of 86% when compared to coronary angiography in a group of unselected patients with end-stage approaches make sense when considering the allocation of cadaver kidneys, especially when organs are in short renal disease [8] . However, local expertise is likely to be an important factor in determining the success of a supply. Renal transplantation is generally cheaper than dialysis and death of a patient with a functioning screening strategy and many renal units have developed their own protocols accordingly. Even when coronary kidney wastes the graft, thus negating the economic benefits of transplantation. Although not discussed, angiograms are performed, the value of this test in predicting future acute coronary events in the context similar principles can be applied to detection and prevention of cerebrovascular, peripheral vascular, and of chronic renal failure has not been established. left ventricular disease in patients considered for renal transplantation.
Minimizing the risk of ischaemic heart disease

Assessing the risk of ischaemic heart disease
The detection of coronary artery disease will not only deny some patients a place on the transplant waiting list, but will also identify those most likely to benefit Perhaps not surprisingly, the presence of pre-transplant ischaemic heart disease has been shown to be a strong from medical or surgical treatment. Both percutaneous transluminal coronary angiography (PTCA) and corindependent predictor of post-transplant cardiovascular events [5] . It therefore seems likely that operative onary artery bypass grafting (CABG) relieve symptoms of angina in patients with chronic renal failure. risks could be minimized and graft survival improved if patients with established coronary disease were However, when compared to individuals without renal failure undergoing CABG, perioperative morbidity and denied access to transplant waiting lists. In many cases, the presence of coexistent ischaemic heart disease will mortality are increased as are restenosis rates following PTCA [9] . In a retrospective comparison of the two be clinically apparent. Guidelines drawn up by the American Society of Transplant Physicians recommend procedures, patients undergoing CABG were shown to have a lower incidence of recurrent angina, myocardial that individuals with angina pectoris, a history of myocardial infarction or congestive cardiac failure infarction and sudden cardiac death [10] . However, at the present time, there are no data confirming that should undergo coronary angiography before any consideration is given to renal transplantation [6 ] .
such intervention improves survival in chronic renal failure. Thus it is unclear whether patients who have Many uraemic patients will have clinically silent disease. Since it is generally not practical to perform undergone revascularization procedures should subsequently be reconsidered for transplant listing. coronary angiography on all individuals considered for transplant listing, other approaches have been recomIschaemic heart disease remains a major cause of morbidity and mortality in the post-transplant period, mended. These include stratification of asymptomatic patients based on the level of risk (as discussed below) even when efforts are made to exclude patients with pre-existing disease. In one follow-up study, 23% of and the use of non-invasive tests to pre-select patients in whom more detailed investigation is appropriate patients who survived with a functioning graft for 15 years developed de novo coronary artery disease during [6 ] . Pre-selection should increase the utility of screening tests that are likely to be more effective in a this period [5] . It is therefore clear that preventative strategies are required to minimize the risks of ischpopulation where the incidence of the disease is high.
Such an approach proved to be effective in a pro-aemic heart disease following renal transplantation. Many risk factors for atherosclerosis can be identispective study of 189 consecutive patients referred for transplantation. Those without risk factors received no fied in patients with chronic renal failure and may help to explain the markedly increased incidence of premafurther cardiac investigation, whilst those considered at risk on the basis of clinical characteristics underwent ture ischaemic heart disease in these individuals. These include smoking, hypertension, diabetes mellitus, thallium myocardial scintigraphy. Over a mean followup period of 47 months, cardiac mortality was consid-dyslipidaemia, increased oxidant stress, elevated procoagulant activity, and hyperhomocysteinaemia [9] . erably higher in the latter group (17 vs 1%, P<0.001). The presence of reversible or fixed perfusion defects However, to date there have been no prospective studies designed to demonstrate that modification of on thallium scans allowing further stratification of patients according to the risk of cardiac mortality [7] . any risk factor will reduce the frequency of cardiovascular events, either pre-or post-transplantation. In the With or without patient pre-selection, the ideal screening strategy for high-risk asymptomatic patients absence of these data, it is tempting to extrapolate from our knowledge based on the general population. has not been established. Whilst the use of exercise electrocardiography, thallium scintigraphy and dopaHowever, this approach should be cautious, since some studies have failed to demonstrate that commonly mine echocardiography have been reported, it is unclear whether these tests have sufficiently high posit-recognized risk factors such as hypertension and hypercholesterolaemia are independently associated with the ive and negative predictive values to allow accurate pre-selection of patients for coronary angiography [6 ] . development of coronary artery disease in the post-transplant period [5] . Current recommendations aimed with chronic renal failure, whether or not they are transplanted. at minimizing the risk of cardiovascular disease complicating chronic renal failure emphasize cessation of 
